Celebrating Australian Commercialisation
Success stories from research organisations and innovative companies around Australia.
Causing 310,000 deaths annually, cervical cancer is the second biggest killer of women globally. But thanks to the Gardasil vaccine, cervical cancer is predicted to be eliminated as a public health threat in Australia by 2028.read more
A personal approach to every bed wetting problem.read more
Clarity is developing next-generation theranostic (diagnostic and therapy) solutions for serious diseases, such as cancer, that are not well treated by current therapies.read more
WAMS simplifies workload allocation, saving time, money and a lot of frustration.read more
This Australian technology allows us to monitor food from the moment it’s picked; optimising the quality, shelf life and taste of all produce.read more
No one likes eating bad meat. MEQ Probe provides real-time information to meat processors which can be shared up the supply chain (distributors, butchers, consumers) and down the supply chain (on-farm growers), providing more transparency to the supply-chain and improving the overall quality.read more
Researchers at Monash have developed a new technique for the Australian dairy industry that reduces costs and environmental impacts while producing powdered milk products. Currently, 40% of Australia’s fresh milk is turned into powdered products, meaning this innovation can make a tremendous impact!read more
Inhibispheres® enhance the corrosion protection of paints and coatings while using 30 times less chemicals than traditional “dumb” anti-corrosion pigments.read more
BioGill technology brings together the power of science and nature to make treating wastewater onsite, simple and easy. They are a biotechnology company manufacturing attached growth, above ground bioreactors that deliver affordable and highly effective wastewater treatment solutions.read more
Sienna’s new in-vitro diagnostic (IVD) is the first ever test for the detection of an important cancer-related biomarker called hTERT. The test is an adjunct to urine cytology testing which is the standard-of-care non-invasive test for bladder cancer.read more
Subscribe to keep up-to-date with incredible stories of Australian innovation.